Quality of published studies supporting off-label and accelerated approval oncology indications

被引：0
|
作者：
Carson, K. R.
Chia, Y.
Sekhar, J.
Coeytaux, R. R.
Wheeler, J. L.
Bennett, C. L.
Abernethy, A. P.
机构：
[1] Washington Univ, St Louis, MO USA
[2] Barnes Jewish Hosp, St Louis, MO 63110 USA
[3] Duke Clin Res Inst, Durham, NC USA
[4] Duke Univ, Med Ctr, Duke Comprehens Canc Ctr, Durham, NC 27710 USA
[5] Northwestern Univ, Feinberg Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA
[6] Duke Univ, Med Ctr, Durham, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.6059
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6059
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Linezolid: effectiveness and safety for approved and off-label indications
    Vardakas, Konstantinos Z.
    Ntziora, Fotinie
    Falagas, Matthew E.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (14) : 2381 - 2400
  • [22] Off-label indications for atypical antipsychotics: A systematic review
    Fountoulakis, K
    Nimatoudis, I
    Iacovides
    Kaprinis, S
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S281 - S281
  • [23] Therapy without Approval - Policies for off-label compassionate use
    Loeffler, H.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2011, 9 : 66 - 66
  • [24] Off-label Use and Approval: a Balancing Act in the Treatment of Minors
    Goepel, Wolfgang
    [J]. DRUG RESEARCH, 2018, 68 : S3 - S3
  • [25] Off-Label Use of Oncology Drugs in a Community Oncology EMR Database
    Stephen, Reejis
    Knopf, Kevin
    Reynolds, Matthew
    Luo, Weixiu
    Fraeman, Kathy
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S62 - S62
  • [26] OFF-LABEL USE OF ONCOLOGY DRUGS IN A COMMUNITY ONCOLOGY EMR DATABASE
    Stephen, R.
    Knopf, K.
    Reynolds, M. W.
    Luo, W.
    Fraeman, K.
    [J]. VALUE IN HEALTH, 2009, 12 (03) : A57 - A57
  • [27] Off-Label Use - an unsolved problem in German oncology
    Langenbuch, T.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 80 - 80
  • [28] OFF-LABEL ONCOLOGY PRESCRIPTION IN ITALY: A LEGAL PERSPECTIVE
    Giuliani, Jacopo
    Maiolli, Valentina
    Bonetti, Andrea
    [J]. EUROPEAN JOURNAL OF ONCOLOGY, 2013, 18 (02): : 85 - 91
  • [29] FDA Accelerated Approval for Malignant Hematology and Oncology Indications in the Canadian Environment
    Ho, Cheryl
    Lim, Howard J. J.
    Regier, Dean A. A.
    [J]. CURRENT ONCOLOGY, 2022, 29 (02) : 402 - 410
  • [30] Reimbursement for cancer treatment: Coverage of off-label drug indications
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (19) : 3206 - 3208
12345